GlassScriptPhysician profile
Rachel A Ewing
NPI 1447482625
$4,158.66
in general payments reported to CMS, 2019-2025
38 companies · $1,080 in 2025
The $1,080 reported for 2025 was more than what 82% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $653 · 2022: $506 · 2023: $731 · 2024: $1,189 · 2025: $1,080.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,999.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $641.19 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $540.92 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Amgen INC. | $408.75 | 2021-2025 | Evenity, Repatha, Otezla |
| Lilly USA, LLC | $406.71 | 2021-2025 | Zepbound, Mounjaro, Jardiance |
| Novo Nordisk INC | $335.22 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $160.09 | 2021-2025 | Bexsero, Rotarix, Shingrix |
| Pfizer INC. | $154.98 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $142.46 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $136.12 | 2021-2025 | Vaxneuvance, Gardasil 9, Rotateq |
| Abbott Laboratories | $122.80 | 2023-2024 | Freestyle Libre 3 |
| Idorsia Pharmaceuticals US INC | $121.40 | 2023-2025 | Quviviq, Quviviq |
| Astellas Pharma US INC | $110.48 | 2021-2025 | Veozah |
| Antares Pharma, INC. | $73.23 | 2021-2023 | Tlando, Xyosted, Nocdurna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $72.54 | 2021-2024 | Xifaxan |
| Janssen Pharmaceuticals, INC | $70.67 | 2021-2023 | Xarelto |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Ewing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.